{{Rsnum
|rsid=2028898
|Gene=GGCX
|Chromosome=2
|position=85550147
|Orientation=plus
|GMAF=0.3251
|Gene_s=GGCX
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.6 | 46.4 | 8.9
| HCB | 47.4 | 43.8 | 8.8
| JPT | 43.4 | 46.0 | 10.6
| YRI | 36.7 | 49.7 | 13.6
| ASW | 49.1 | 35.1 | 15.8
| CHB | 47.4 | 43.8 | 8.8
| CHD | 54.6 | 36.1 | 9.3
| GIH | 76.2 | 20.8 | 3.0
| LWK | 34.5 | 51.8 | 13.6
| MEX | 60.3 | 34.5 | 5.2
| MKK | 33.3 | 52.6 | 14.1
| TSI | 49.0 | 40.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22366784
|Title=Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
}}

{{PMID|18535201|OA=1
}} A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.

{{PMID|19436136|OA=1
}} Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}